PAPPA and breast cancer: Immunoperoxidase based examination of PAPP-A, pregnancy specific β-1-glycoprotein, and placental protein five in primary tumors and metastases from 30 patients undergoing low- or standard-dose combination chemotherapy for stage II BC was evaluated in conjunction with 25 traditional clinicopathologic features in relation to early recurrence (within two years).